Shanghai, China

Kai Long

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2025

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: The Innovative Contributions of Inventor Kai Long

Introduction

Kai Long, a prominent inventor based in Shanghai, China, has made significant strides in the field of biotechnology. With a total of six patents to his name, he has demonstrated a strong commitment to advancing scientific knowledge and creating innovative solutions that address pressing medical challenges.

Latest Patents

Among his latest inventions is a groundbreaking bispecific recombinant protein designed for tumor targeting. This protein combines a high-affinity tumor-targeting arm with a low-affinity fusion protein that blocks the interaction of CD47 with SIRPα. Notably, the corresponding antibody to the high-affinity arm does not bind to CD47, ensuring that its binding affinity to the target antigen on the tumor cell is at least six times greater than that of the monomer fusion protein homodimer associated with the low-affinity fusion protein. This innovation holds great promise for developing new medicaments aimed at treating tumors, as it also includes nucleic acid molecules encoding the recombinant proteins.

Another important patent of his focuses on maximally parallel test script execution. This invention involves dividing a test script into tests arranged in a sequential order and generating an analysis tree to identify unique paths that successfully cover all tests. Each test appears only in one unique path of the maximally parallel subset, showcasing a method that enhances the efficiency of test execution.

Career Highlights

Kai Long has had an impressive career, contributing his expertise to notable organizations such as Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. His work in these companies not only highlights his extensive knowledge of pharmaceuticals but also reflects his role in driving innovation in biotechnology.

Collaborations

Throughout his career, Kai has collaborated with talented individuals like Zehong Wan and Yingxia Sang, a distinguished female professional in her field. These collaborations have fostered a productive environment, allowing for the exchange of innovative ideas and enhancing the overall impact of their work.

Conclusion

In summary, Kai Long stands out as a remarkable inventor whose contributions in the realm of biotechnology continue to shape the future of medical treatments. With his groundbreaking patents and collaborations, he exemplifies the spirit of innovation and the pursuit of knowledge in the ever-evolving field of science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…